Clinical Trial Update: A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment. [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating whether immunotherapy can be safely given to adults with glioblastoma or gliosarcoma before their standard treatment; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: University College, London | Conditions: Glioblastoma, Gliosarcoma, Adult | Phase 1 | Status: RECRUITING